Cancer Detection and Diagnosis Research in Kentucky
Cancer Detection and Diagnosis Research (93.394) awarded $7.4 million to recipients in Kentucky in 9 grants from fiscal 2021 to 2025, 0.3% of the program's national total. The University of Kentucky Research Foundation received the most, $2.2 million.
- Awarded in Kentucky$7.4 million
- Awards9
- Share of the program0.3%
- Rank among states34th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $1.2 million |
| FY 2022 | 3 | $725,400 |
| FY 2023 | 4 | $1.3 million |
| FY 2024 | 3 | $2.0 million |
| FY 2025 | 3 | $2.1 million |
Recipients in Kentucky
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The University of Kentucky Research Foundation | Colleges and universities | 5 | $2.2 million |
| Bioptics Technology LLC | Small businesses | 1 | $2.0 million |
| Lagrange Scientific LLC | Small businesses | 1 | $1.5 million |
| University of Louisville | Nonprofits | 1 | $1.3 million |
| Wild Dog Physics LLC | Small businesses | 1 | $451,608 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Kentucky?
$7.4 million from fiscal 2021 to 2025, across 9 awards. Kentucky ranks 34th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Kentucky?
The largest recipient is The University of Kentucky Research Foundation, with $2.2 million in 5 awards. Next are Bioptics Technology LLC and Lagrange Scientific LLC.
Can organizations in Kentucky apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Kentucky
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Head Start
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)